Interest of variations in miR-152 and miR-122 in a series of hepatocellular carcinomas related to HCV infection

HIV / AIDS

Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies

J Hepatol.

Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A, Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort

doi: 10.1016/j.jhep.2019.03.032.

Viral Infections, Non-HIV

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

N Engl J Med.

Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, Coppolino A, Kusztos AE, Johnson ME, Chen K, Haddad EA, Fanikos J, Harrington DP, Camp PC, Baden LR, DONATE HCV Trial Team, the DONATE HCV Trial Team

doi: 10.1056/NEJMoa1812406.

HIV / AIDS

Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV

AIDS

Guardigni V, Toschi A, Badia L, Del Turco ER, Salsi E, Cristini F, Sighinolfi L, Fabbri G, Massari M, Cuomo G, Viale P, Verucchi G, RECHIV study group.

doi: 10.1097/QAD.0000000000002973

Viral Infections, Non-HIV

Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection

Swiss Med Wkly.

Bregenzer A, Warmann N, Ottiger C, Fux CA

doi: 10.4414/smw.2019.20137.

Risk Behaviors for Contact Lens-Related Eye Infections Among Adults and Adolescents - United States, 2016

MMWR Morb Mortal Wkly Rep.

Cope JR, Collier SA, Nethercut H, Jones JM, Yates K, Yoder JS

doi: 10.15585/mmwr.mm6632a2.

HIV / AIDS

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Clin Infect Dis.

Naggie S, Fierer DS, Hughes MD, Kim AY, Luetkemeyer A, Vu V, Roa J, Rwema S, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RT, Acquired Immunodeficiency Syndrome Clinical Trials Group (ACTG) A5327 Study Team .

doi: 10.1093/cid/ciy913.

Viral Infections, Non-HIVFurther Publications Infectiology

HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma

J Infect Dis

Liu Z, Huang CJ, Huang YH, Pan MH, Lee MH, Yu KJ, Pfeiffer RM, Viard M, Yuki Y, Gao X, Carrington M, Chen CJ, Hildesheim A, Yang HI, REVEAL-HBV Study Group.

doi: 10.1093/infdis/jiab207

Bacterial Infections

Catheter-related bloodstream infections with coagulase-negative staphylococci: are antibiotics necessary if the catheter is removed?

Antimicrob Resist Infect Control.

Hebeisen UP, Atkinson A, Marschall J, Buetti N

doi: 10.1186/s13756-019-0474-x.

Viral Infections, Non-HIV

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

N Engl J Med.

Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S; POLARIS-1 and POLARIS-4 Investigators

doi: 10.1056/NEJMoa1613512.

Related content

Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV

Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection

Risk Behaviors for Contact Lens-Related Eye Infections Among Adults and Adolescents - United States, 2016

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma

Catheter-related bloodstream infections with coagulase-negative staphylococci: are antibiotics necessary if the catheter is removed?

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection